InspireMD (NSPR)
(Delayed Data from NSDQ)
$2.69 USD
-0.10 (-3.58%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $2.75 +0.06 (2.23%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2025
Time: BMO |
6/2025 | $-0.24 | 0.00% |
Earnings Summary
For their last quarter, InspireMD (NSPR) reported earnings of -$0.22 per share, missing the Zacks Consensus Estimate of -$0.17 per share. This reflects a negative earnings surprise of 29.41%. Look out for NSPR's next earnings release on August 05, 2025. For the next earning release, we expect the company to report earnings of -$0.24 per share, reflecting a year-over-year decrease of 9.09%.
Earnings History
Price & Consensus
Zacks News for NSPR
InspireMD Launches CGuard Prime Carotid Stent System in the U.S.
NSPR: What are Zacks experts saying now?
Zacks Private Portfolio Services
InspireMD, Inc. (NSPR) Reports Q1 Loss, Tops Revenue Estimates
Globus Medical (GMED) Lags Q1 Earnings and Revenue Estimates
IQVIA Holdings (IQV) Surpasses Q1 Earnings and Revenue Estimates
NSPR FAQs
InspireMD, Inc. (NSPR) has announced they will report their next quarter earnings on August 05, 2025. For the next earning release, we expect the company to report earnings of $-0.24 per share, reflecting a year-over-year decrease of -9.09%.
InspireMD, Inc. has announced they will report their previous quarter earnings after the close of the market on August 05, 2025.
The Zacks Consensus Estimate for InspireMD, Inc. (NSPR) for the quarter ending June 2025 is $-0.24 a share. We expect InspireMD, Inc. (NSPR) to report earnings in line with the consensus estimate of $-0.24 per share
In the earnings report for the quarter ending in June 2024, InspireMD, Inc. (NSPR) announced earnings of $-0.22 per share versus the Zacks Consensus Estimate of $-0.19 per share, representing a surprise of 15.79%.